Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LINCOLN | NSE
-36.50
-4.72%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
737.00
775.55
780.00
728.55
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold anti-allergic and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins minerals and antioxidants; anti-bacterial anti-viral and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic anti-convulsant anti-depressant and anti-diabetic; cardiac anti-hypertensives and diuretic; and anti-diarrheal anti-spasmodic and laxative as well as dermatologist preparations gynecological products gastrointestinal rang otology products and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics. The company was incorporated in 1979 and is based in Ahmedabad India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
51.9%1 month
39.9%3 months
32.0%6 months
32.5%15.67
-
2.59
0.00
0.00
10.35
2.42
-
1.02B
14.78B
176.81M
0.23
13.25
24.60
8.60
17.04
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
115.10
Range1M
156.25
Range3M
218.35
Rel. volume
0.59
Price X volume
62.41M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 127.88 | 13.43B | -2.66% | 17.47 | 10.32% |
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 46.62 | 10.75B | -2.59% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 405.85 | 10.74B | -1.04% | 53.99 | 4.77% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 383.15 | 10.70B | -4.01% | n/a | 119.57% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1479.35 | 8.44B | -0.14% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 253.35 | 8.30B | -1.11% | 16.51 | 416.89% |
Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 137.79 | 8.14B | -1.82% | 2.10 | 1.78% |
Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 370.4 | 5.99B | -1.71% | 50.24 | 17.95% |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 463.15 | 5.84B | -2.80% | 72.99 | 15.37% |
Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 112.64 | 5.52B | -0.58% | 31.56 | 45.58% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 10.35 | - | Cheaper |
Ent. to Revenue | 2.42 | - | Cheaper |
PE Ratio | 15.67 | 47.84 | Cheaper |
Price to Book | 2.59 | 6.55 | Cheaper |
Dividend Yield | 0.23 | - | Poor |
Std. Deviation (3M) | 32.04 | - | Lower Risk |
Debt to Equity | 0.00 | 0.34 | Cheaper |
Debt to Assets | 0.00 | 0.17 | Cheaper |
Market Cap | 14.78B | - | Emerging |